Use of ML dipstick as a tool to classify leprosy patients

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 68, Issue 4, 2000, Pages 456-463

  Buhrer Sekula, S ^a   Sarno, E N ^a   Oskam, L ^a   Koop, S ^a   Wichers, I ^a   Nery, J A C ^a   Vieira, L M ^a   De Matos, H J ^a   Faber, W R ^a   Klatser, P R ^a  

^a ROYAL TROPICAL INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; PHENOLIC GLYCOLIPID I; RIFAMPICIN;

ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LEPROSY; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; PREDICTION;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; GLYCOLIPIDS; HUMANS; IMMUNOGLOBULIN M; LEPROSY; MYCOBACTERIUM LEPRAE; REAGENT STRIPS; SKIN;

EID: 0034450780     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Antibodies to nolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: Evolution during therapy
2. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis
3. Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid-I in the serology of leprosy
4. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae
5. The use of whole blood in a dipstick assay for detection of antibodies to Mycobacterium leprae: A field evaluation
6. Cross-sectional assessment of ELISA reactivity in leprosy patients, contacts, and normal population using the semi-synthetic antigen natural disaccharide octyl bovine serum albumin (ND-O-BSA) in Cebu, The Philippines
7. Chemical synthesis and seroreactivity of O-(3,6-di-O-methyl-beta-D-glucopyranosyl)-(1 - 4)-O-(2,3-di-O-me)
8. Follow-up of multibacillary leprosy patients using a phenolic glycolipid-I-based ELISA. Do increasing ELISA-values after discontinuation of treatment indicate relapse?
9. Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens
10. Sensitivity and specificity of methods of classification of leprosy without use of skin-smear examination
11. The effects of chemotherapry on antibody levels in lepromatous patients
12. Field evaluation of an ELISA to detect antibody in leprosy patients and their contacts
13. Serum antibodies to defined carbohydrate antigens during the course of treated leprosy
14. Quantitation of IgM antibodies to the M. leprae synthetic disaccharide can predict early bacterial multiplication in leprosy
15. Evaluation of Mycobacterium leprae antigens in the monitoring of a dapsone-based chemotherapy of previously untreated lepromatous patients in Cebu, Philippines
16. ELISA detection of IgM anti-bodies against phenolic glycolipid-I in the management of leprosy: A comparison between laboratories
17. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan
18. Comparison of bacillary indexes in slit-skin smears, skin and nerve biopsies; a study from Malawi
19. Classification of leprosy according to immunity; a five-group system
20. Serological monitoring of the response to chemotherapy in leprosy patients
21. Operational value of serological measurements in multibacillary leprosy patients: Clinical and bacteriological correlates of antibody responses
22. The allocation of leprosy patients into paucibacillary and multibacillary groups for multidrug therapy, taking into account the number of body areas affected by skin, or skin and nerve lesions